To further reveal the mechanism of BRD7 in tumor development and PTX chemotherapy sensitization in breast cancer, we screened and identified a potential E3 ubiquitin ligase TRIM2,5 interacting with BRD7 by IP-MS. Here, TRIM2 is linked to breast carcinoma.